Adaptation within mitochondrial oxidative phosphorylation supercomplexes and membrane viscosity during degeneration of dopaminergic neurons in an animal model of early Parkinson's disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1862, Issue 4, 2016, Pages 741-753

  Kuter, Katarzyna ^a   Kratochwil, Manuela ^b   Berghauzen Maciejewska, Klemencja ^a   Głowacka, Urszula ^a   Sugawa, Michiru D ^b,c   Ossowska, Krystyna ^a   Dencher, Norbert A ^b  

^a POLISH ACADEMY OF SCIENCES   (Poland)

^b DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Compensatory processes; Mitochondrial membrane viscosity; Neurodegeneration; OxPhos supercomplex assembly; Parkinson's disease

Indexed keywords

CYTOCHROME C OXIDASE; DOPAMINE; NORADRENALIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; ENZYME ACTIVITY; LOCOMOTION; MALE; MITOCHONDRIAL MEMBRANE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; RAT; STEREOLOGY; SUBSTANTIA NIGRA; VISCOSITY;

EID: 84958213468     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2016.01.022     Document Type: Article

References (68)

1. Acin-Perez R., Enriquez J.A. The function of the respiratory supercomplexes: the plasticity model. Biochim. Biophys. Acta 2014, 1837:444-450.
2. Benard G., Rossignol R. Mitochondrial fluidity matters. Focus on "Inherited complex I deficiency is associated with faster protein diffusion in the matrix of moving mitochondria". Am. J. Physiol. Cell Physiol. 2008, 294:C1123.
3. Benard G., Rossignol R. Ultrastructure of the mitochondrion and its bearing on function and bioenergetics. Antioxid. Redox Signal. 2008, 10:1313-1342.
4. Berghauzen-Maciejewska K., Kuter K., Kolasiewicz W., Głowacka U., Dziubina A., Ossowska K., Wardas J. Pramipexole but not imipramine or fluoxetine reverses the "depressive-like" behaviour in a rat model of preclinical stages of Parkinson's disease. Behav. Brain Res. 2014, 271:343-353.
5. Bindoff L.A., Birch-Machin M.A., Cartlidge N.E., Parker W.D., Turnbull D.M. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J. Neurol. Sci. 1991, 104:203-208.
6. Buck K.J., Walter N.A., Denmark D.L. Genetic variability of respiratory complex abundance, organization and activity in mouse brain. Genes Brain Behav. 2014, 13:135-143.
7. Burke R.E., O'Malley K. Axon degeneration in Parkinson's disease. Exp. Neurol. 2013, 246:72-83.
8. Castañeda E., Whishaw I.Q., Robinson T.E. Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J. Neurosci. 1990, 10:1847-1854.
9. Castelein N., Muschol M., Dhondt I., Cai H., De Vos W.H., Dencher N.A., Braeckman B.P. Mitochondrial efficiency is increased in axenically cultured Caenorhabditis elegans. Exp. Gerontol. 2014, 56:26-36.
10. Chochina S.V., Avdulov N.A., Igbavboa U., Cleary J.P., O'Hare E.O., Wood W.G. Amyloid beta-peptide1-40 increases neuronal membrane fluidity: role of cholesterol and brain region. J. Lipid Res. 2001, 42:1292-1297.
11. Clement A.B., Gimpl G., Behl C. Oxidative stress resistance in hippocampal cells is associated with altered membrane fluidity and enhanced nonamyloidogenic cleavage of endogenous amyloid precursor protein. Free Radic. Biol. Med. 2010, 48:1236-1241.
12. Corti O., Brice A. Mitochondrial quality control turns out to be the principal suspect in parkin and PINK1-related autosomal recessive Parkinson's disease. Curr. Opin. Neurobiol. 2013, 23:100-108.
13. Dani D., Shimokawa I., Komatsu T., et al. Modulation of oxidative phosphorylation machinery signifies a prime mode of anti-ageing mechanism of calorie restriction in male rat liver mitochondria. Biogerontology 2010, 11:321-334.
14. Davey G.P., Clark J.B. Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria. J. Neurochem. 1996, 66:1617-1624.
15. Deepa S.S., Pulliam D., Hill S., et al. Improved insulin sensitivity associated with reduced mitochondrial complex IV assembly and activity. FASEB J. 2013, 27:1371-1380.
16. Dencher N.A. Dynamic interactions between membrane constituents studied by biophysical techniques and functional reconstitution of membrane proteins into lipid bilayers. NATO ASI Series, Dynamics and Biogenesis of Membranes 1990, Springer-Verlag, Berlin Heidelberg.
17. Deumens R., Blokland A., Prickaerts J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 2002, 175:303-317.
18. Dubinsky J.M. Heterogeneity of nervous system mitochondria: location, location, location!. Exp. Neurol. 2009, 218:293-307.
19. Eckmann J., Eckert S.H., Leuner K., Muller W.E., Eckert G.P. Mitochondria: mitochondrial membranes in brain ageing and neurodegeneration. Int. J. Biochem. Cell Biol. 2013, 45:76-80.
20. Fabelo N., Martín V., Santpere G., Marín R., Torrent L., Ferrer I., Díaz M. Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease. Mol. Med. 2011, 17:1107-1118.
21. Frenzel M., Rommelspacher H., Sugawa M.D., Dencher N.A. Ageing alters the supramolecular architecture of OxPhos complexes in rat brain cortex. Exp. Gerontol. 2010, 45:563-572.
22. García J.J., López-Pingarrón L., Almeida-Souza P., et al. Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review. J. Pineal Res. 2014, 56:225-237.
23. García J.J., Piñol-Ripoll G., Martínez-Ballarín E., et al. Melatonin reduces membrane rigidity and oxidative damage in the brain of SAMP8 mice. Neurobiol. Aging 2011, 32:2045-2054.
24. Genova M.L., Baracca A., Biondi A., et al. Is supercomplex organization of the respiratory chain required for optimal electron transfer activity?. Biochim. Biophys. Acta 2008, 1777:740-746.
25. Genova M.L., Lenaz G. A critical appraisal of the role of respiratory supercomplexes in mitochondria. Biol. Chem. 2013, 394:631-639.
26. Genova M.L., Lenaz G. Functional role of mitochondrial respiratory supercomplexes. Biochim. Biophys. Acta 2014, 1837:427-443.
27. Glinka Y., Tipton K.F., Youdim M.B. Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine. Eur. J. Pharmacol. 1998, 351:121-129.
28. Glinka Y.Y., Youdim M.B. Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur. J. Pharmacol. 1995, 292:329-332.
29. Gundersen H.J., Jensen E.B. Stereological estimation of the volume-weighted mean volume of arbitrary particles observed on random sections. J. Microsc. 1985, 138:127-142.
30. Hattingen E., Magerkurth J., Pilatus U., Mozer A., Seifried C., Steinmetz H., Zanella F., Hilker R. Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease. Brain 2009, 132:3285-3297.
31. Hornykiewicz O. Biochemical aspects of Parkinson's disease. Neurology 1998, 51:S2-S9.
32. Janetzky B., Hauck S., Youdim M.B., Riederer P., Jellinger K., Pantucek F., Zöchling R., Boissl K.W., Reichmann H. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci. Lett. 1994, 169:126-128.
33. Kim-Han J.S., Antenor-Dorsey J.A., O'Malley K.L. The parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons. J. Neurosci. 2011, 31:7212-7221.
34. Kolasiewicz W., Kuter K., Berghauzen K., Nowak P., Schulze G., Ossowska K. 6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats. Brain Res. 2012, 1477:59-73.
35. Krause F., Seelert H. Detection and analysis of protein-protein interactions of organellar and prokaryotic proteomes by blue native and colorless native gel electrophoresis. Curr. Protoc. Protein Sci. 2008, (Chapter 19, Unit 19.18).
36. Kumar R., Agarwal A.K., Seth P.K. Free radical-generated neurotoxicity of 6-hydroxydopamine. J. Neurochem. 1995, 64:1703-1707.
37. Kupsch A., Schmidt W., Gizatullina Z., et al. 6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson's disease: respirometric, histological, and behavioral analyses. J. Neural Transm. 2014, 121:1245-1257.
38. Kuter K., Kolasiewicz W., Gołembiowska K., Dziubina A., Schulze G., Berghauzen K., Wardas J., Ossowska K. Partial lesion of the dopaminergic innervation of the ventral striatum induces "depressive-like" behavior of rats. Pharmacol. Rep. 2011, 63:1383-1392.
39. Kuter K., Smiałowska M., Wierońska J., et al. Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats. Brain Res. 2007, 1155:196-207.
40. Lapuente-Brun E., Moreno-Loshuertos R., Acín-Pérez R., et al. Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science 2013, 340:1567-1570.
41. Liang C.L., Wang T.T., Luby-Phelps K., German D.C. Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease. Exp. Neurol. 2007, 203:370-380.
42. Lin A.L., Pulliam D.A., Deepa S.S., et al. Decreased in vitro mitochondrial function is associated with enhanced brain metabolism, blood flow, and memory in Surf1-deficient mice. J. Cereb. Blood Flow Metab. 2013, 33:1605-1611.
43. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
44. Lu X., Kim-Han J.S., Harmon S., Sakiyama-Elbert S.E., O'Malley K.L. The parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons. Mol. Neurodegener. 2014, 9:17.
45. Mann V.M., Cooper J.M., Krige D., Daniel S.E., Schapira A.H., Marsden C.D. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 1992, 115(Pt 2):333-342.
46. Maranzana E., Barbero G., Falasca A.I., Lenaz G., Genova M.L. Mitochondrial respiratory supercomplex association limits production of reactive oxygen species from complex I. Antioxid. Redox Signal. 2013, 19:1469-1480.
47. Meininger V., Phan T., Camelin J.C., et al. Methylation of erythrocyte membrane phospholipids: correlation with membrane viscosity. Study of normal and parkinsonian subjects. Rev. Neurol. (Paris) 1984, 140:488-492.
48. Nicolson G.L. The fluid-mosaic model of membrane structure: still relevant to understanding the structure, function and dynamics of biological membranes after more than 40 years. Biochim. Biophys. Acta 2014, 1838:1451-1466.
49. Pacelli C., Giguère N., Bourque M.J., Lévesque M., Slack R.S., Trudeau L. Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons. Curr. Biol. 2015, 25:2349-2360.
50. Pulliam D.A., Bhattacharya A., Van Remmen H. Mitochondrial dysfunction in aging and longevity: a causal or protective role?. Antioxid. Redox Signal. 2013, 19:1373-1387.
51. Pulliam D.A., Deepa S.S., Liu Y., et al. Complex IV-deficient Surf1(-/-mice initiate mitochondrial stress responses. Biochem. J. 2014, 462:359-371.
52. Reifschneider N.H., Goto S., Nakamoto H., Takahashi R., Sugawa M., Dencher N.A., Krause F. Defining the mitochondrial proteomes from five rat organs in a physiologically significant context using 2D blue-native/SDS-PAGE. J. Proteome Res. 2006, 5:1117-1132.
53. Robinson T.E., Castañeda E., Whishaw I.Q. Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies. Can. J. Psychol. 1990, 44:253-275.
54. Saito Y., Nishio K., Ogawa Y., Kinumi T., Yoshida Y., Masuo Y., Niki E. Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action. Free Radic. Biol. Med. 2007, 42:675-685.
55. Schapira A.H., Cooper J.M., Dexter D., Clark J.B., Jenner P., Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 1990, 54:823-827.
56. Schapira A.H., Mann V.M., Cooper J.M., Dexter D., Daniel S.E., Jenner P., Clark J.B., Marsden C.D. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 1990, 55:2142-2145.
57. Schon E.A., Dencher N.A. Heavy breathing: energy conversion by mitochondrial respiratory supercomplexes. Cell Metab. 2009, 9:1-3.
58. Schäfer E., Seelert H., Reifschneider N.H., Krause F., Dencher N.A., Vonck J. Architecture of active mammalian respiratory chain supercomplexes. J. Biol. Chem. 2006, 281:15370-15375.
59. Schägger H., Pfeiffer K. Supercomplexes in the respiratory chains of yeast and mammalian mitochondria. EMBO J. 2000, 19:1777-1783.
60. Sharon R., Bar-Joseph I., Mirick G.E., Serhan C.N., Selkoe D.J. Altered fatty acid composition of dopaminergic neurons expressing alpha-synuclein and human brains with alpha-synucleinopathies. J. Biol. Chem. 2003, 278:49874-49881.
61. Shults C.W., Haas R.H., Passov D., Beal M.F. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann. Neurol. 1997, 42:261-264.
62. Stott S.R., Barker R.A. Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease. Eur. J. Neurosci. 2014, 39:1042-1056.
63. Subramaniam S.R., Chesselet M.F. Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Prog. Neurobiol. 2013, 106-107:17-32.
64. Sugawa M., Coper H., Schulze G., Yamashina I., Krause F., Dencher N.A. Impaired plasticity of neurons in aging. biochemical, biophysical, and behavioral studies. Ann. N. Y. Acad. Sci. 1996, 786:274-282.
65. Truong L., Allbutt H., Kassiou M., Henderson J.M. Developing a preclinical model of Parkinson's disease: a study of behaviour in rats with graded 6-OHDA lesions. Behav. Brain Res. 2006, 169:1-9.
66. van Diepeningen A.D., Maas M.F., Huberts D.H., et al. Calorie restriction causes healthy life span extension in the filamentous fungus Podospora anserina. Mech. Ageing Dev. 2010, 131:60-68.
67. Wernicke C., Hellmann J., Zieba B., Kuter K., Ossowska K., Frenzel M., Dencher N.A., Rommelspacher H. 9-Methyl-beta-carboline has restorative effects in an animal model of Parkinson's disease. Pharmacol. Rep. 2010, 62:35-53.
68. Witt S.N. Lipid disequilibrium in biological membranes, a possible pathway to neurodegeneration. Commun. Integr. Biol. 2014, 7.